Nachrichten zur Viatris Aktie

VTRS DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRS

NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

VTRS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRS

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Alcohol Use Disorder (AUD) Market Trends and Forecasts (2025-2030) by Drug Class, Treatment Type, End User, Distribution Channel, Formulation, Region and Country

Featuring Profiles of Key Players Alkermes, H. Lundbeck, Teva Pharmaceutical Industries, Viatris, Sandoz International and More Featuring Profiles of Key…

VTRS SECURITIES NOTICE: Did Viatris Inc. Commit Securities Fraud? Contact BFA Law about the Class Action Lawsuit by June 3

Viatris Inc. investors that lost money are encouraged to contact BFA Law before June 3, 2025 class action deadline.…

Viatris (NASDAQ: VTRS) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

PHILADELPHIA, May 23, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Canopy Growth, Viatris, Bakkt, and Cerevel and Encourages Investors to Contact the Firm

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Lawsuit – VTRS

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, May 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Viatris, Canopy Growth, Everus, and BigBear and Encourages Investors to Contact the Firm

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Viatris Inc. Class Action: Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 – VTRS

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris"…

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit -- Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)

Viatris Inc. investors that lost money are encouraged to contact BFA Law before June 3, 2025 class action deadline.…

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS

NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

3 Beaten-Down Stocks That Are Trading Below Their Book Values

A companys book value is equal to its total assets, less its liabilities. Book value does not consider the future…

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of…

Viatris Inc. (VTRS) Barclays 27th Annual Global Healthcare Conference (Transcript)

…

Whats in the Cards for Viatris Stock This Q4 Earnings?

VTRS Q4 results are likely to gain from new product launches in all major geographies.…

Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

…

FDA restricts import of certain Viatris products due to plant violations By Investing.com

FDA restricts import of certain Viatris products due to plant violations…

Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)

…

Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)

…

Theravances Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

TBPH beats third-quarter estimates for both sales and earnings. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

We recently published a list of 8 Stocks Under $20 To Invest In Now. In this article, we are going…

Aktienmarkt: Kurs der Viatris-Aktie im Minus (10,0972 €)

An der US-amerikanischen Börse notiert das Wertpapier von Viatris zur Stunde leichter. Der jüngste Kurs betrug 11,20 US-Dollar. An der…

US Biosimilar Market Research 2024-2028 Featuring Leading Players - Pfizer, Novartis, Amgen, Samsung Biologics, Celltrion, and Viatris

Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "US Biosimilar Market: Insights & Forecast (2024-2028)" report has been…

Viatris Inc. (VTRS) Q2 2024 Earnings Call Transcript

…

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Theravance (TBPH) misses second-quarter estimates on both fronts. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…